Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Use of Desferal and Adjuvants for Prevention of ARDS in Hospitalised Cases Documented With Covid 19 Infection: A Randomized Controlled Trial

NCT04389801 is registered in ClinicalTrials.gov with Hesham Al-Inany as lead sponsor.

NCT NCT04389801
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04389801 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Use of Desferal and Adjuvants for Prevention of ARDS in Hospitalised Cases Documented With Covid 19 Infection: A Randomized Controlled Trial
Lead sponsor
Hesham Al-Inany
Phase
Phase 4
Overall status
Unknown status
Start date
June 1, 2020
Completion date
December 31, 2020
Enrollment
200 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

covid 19